Chasity Sullivan
Family Medicine · Fort Smith, ARNPI 1851088561
Payments from drug & device makers
Across 368 payments — averaging $21.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$771
- EMD Serono, Inc.$757
- Novartis$683
- AbbVie$617
- SK Life Science, Inc.$584
- Pfizer$540
- plus $4K from 29 others
What the payments were for
- Food & beverage$7,744100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 31 | $771 |
| EMD Serono, Inc. | 27 | $757 |
| Novartis | 36 | $683 |
| AbbVie | 54 | $617 |
| SK Life Science, Inc. | 22 | $584 |
| Pfizer | 37 | $540 |
| MDD US Operations, LLC | 11 | $498 |
| Kyowa Kirin, Inc. | 14 | $437 |
| Neurocrine Biosciences, Inc. | 19 | $355 |
| Lundbeck LLC | 14 | $306 |
| AstraZeneca(2 entities) | 16 | $304 |
| Genentech USA, Inc. | 8 | $228 |
| Teva Pharmaceuticals USA, Inc. | 11 | $202 |
| Eisai Inc. | 10 | $196 |
| Neurelis, Inc. | 5 | $139 |
| ANI Pharmaceuticals, Inc. | 5 | $135 |
| Bristol Myers Squibb | 7 | $116 |
| Averitas Pharma Inc. | 3 | $109 |
| Banner Life Sciences, LLC | 5 | $94 |
| Catalyst Pharmaceuticals, Inc. | 5 | $88 |
| Amgen | 4 | $86 |
| Amneal Pharmaceuticals LLC | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Argenx US, Inc. | 3 | $57 |
| Boston Scientific | 1 | $51 |
| Tanabe Pharma America, Inc. | 2 | $43 |
| Biogen | 2 | $41 |
| TG Therapeutics, Inc. | 1 | $37 |
| Jazz Pharmaceuticals Inc. | 1 | $30 |
| Impel Pharmaceuticals Inc. | 1 | $24 |
| Harmony Biosciences LLC | 1 | $22 |
| Livanova USA, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Corium, LLC | 2 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,744 in reported general payments places this provider in the 90th percentile of 1,347 family medicine providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 23 | $464,916 |
| IngrezzaValbenazine Tosylate | 22 | $179,954 |
| Emgality PenGalcanezumab-Gnlm | 44 | $43,445 |
| Nurtec OdtRimegepant Sulfate | 22 | $29,569 |
| QuliptaAtogepant | 26 | $29,256 |
| NourianzIstradefylline | 13 | $25,334 |
| Aimovig AutoinjectorErenumab-Aooe | 31 | $24,658 |
| UbrelvyUbrogepant | 18 | $21,207 |
| Gabapentin | 215 | $3,225 |
| Memantine Hcl | 190 | $2,575 |
| Levetiracetam | 161 | $2,327 |
| Primidone | 137 | $2,196 |
| Scopolamine | 15 | $2,108 |
| Carbamazepine ErCarbamazepine | 26 | $1,596 |
| Sumatriptan Succinate | 74 | $1,567 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerOctagam, Nurtec Odt | $540 | $494,48645 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $355 | $179,95422 claims |
| AbbVieQulipta, Ubrelvy | $617 | $50,46244 claims |
| Kyowa Kirin, Inc.Nourianz | $437 | $25,33413 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide, Mycophenolate Mofetil | $81 | $1,27735 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,347 family medicine providers in Arkansas.
Other family medicine in Fort Smith
- Glenn GibbonsFort Smith$179K
- Thinh NguyenFort Smith$28K
- Allen BeachyFort Smith$21K
- Michael CallawayFort Smith$15K
- George KonisLittle Rock$26.6M
- Kevin RobertsLittle Rock$2.5M
- Derek LewisLittle Rock$1.7M
- Jodi SansonHot Springs$1.7M
- Senthil RaghavanLittle Rock$496K
- Broderick EatonWynne$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.